Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation.
CONCLUSION: Hepatic iron content might be associated with poorer prognosis in patients with iron overload that underwent alloHSCT.
PMID: 27521305 [PubMed - as supplied by publisher]
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Sivgin S, Baldane S, Deniz K, Zararsiz G, Kaynar L, Cetin M, Unal A, Eser B Tags: Clin Lymphoma Myeloma Leuk Source Type: research
More News: Cancer & Oncology | Iron | Liver | Liver Transplant | Lymphoma | Myeloma | Pathology | Statistics | Stem Cell Therapy | Stem Cells | Study | Transplant Surgery | Transplants | Urology & Nephrology